Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer

YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN and JUN-JUN YEH
Anticancer Research November 2012, 32 (11) 5087-5091;
YIN LIN
1Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WAN-YU LIN
1Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
2Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-HUNG KAO
2Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
3Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KUO-YANG YEN
3Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
4Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHANG-WEN CHEN
2Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
5Department of Radiation Therapy and Oncology, China Medical University Hospital, Taichung, Taiwan
6College of Medicine, Taipei Medical University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vincent1680616@yahoo.com.tw Cych07239@gmail.com
JUN-JUN YEH
7Department of Research, Chiayi Christian Hospital, Chia-Yi, Chia Nan University of Pharmacy and Science, Tainan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vincent1680616@yahoo.com.tw Cych07239@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    A: Disease-free survival curves according to early standardized uptake values (eSUVm). Data represent eSUVm >2.5 and eSUVm ≤2.5. B: Disease-free survival curves according to delayed SUVmax (lSUVm). Data represent lSUVm >3.4 and lSUVm ≤3.4.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Disease-free survival curves based on metabolic tumor volume2.5 >9.8 ml and MTV2.5 ≤9.8 ml.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research: 32 (11)
Anticancer Research
Vol. 32, Issue 11
November 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer
YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN, JUN-JUN YEH
Anticancer Research Nov 2012, 32 (11) 5087-5091;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer
YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN, JUN-JUN YEH
Anticancer Research Nov 2012, 32 (11) 5087-5091;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of Shape and Textural Features from CT as Prognostic Biomarkers in Non-small Cell Lung Cancer
  • Google Scholar

More in this TOC Section

  • Triage Process at Endoscopy With ColonView Fecal Immunochemical Test (FIT) Will Enhance Diagnostic Accuracy (DA) of Colorectal Cancer Screening
  • Laparoscopic Colorectal Cancer Surgery for Patients With Severe Chronic Heart Failure
  • Clinical Impact of Prehabilitation on Elective Laparoscopic Surgery in Frail Octogenarians With Colorectal Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • 2-Fluoro-2-deoxy-D-glucose (F-18 FDG)
  • positron-emission tomography–computed tomography (PET-CT)
  • Non-small cell lung cancer (NSCLC)
  • metabolic tumor volume (MTV)
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire